Godrej Agrovet (GODREJAGRO) Q4 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 24/25 earnings summary
8 Jul, 2026Executive summary
Achieved highest-ever standalone profitability in FY 2025, with consolidated EBITDA up 11.6% to ₹845 crore and PAT up 4.5% to ₹386 crore, excluding non-recurring items and Astec.
FY25 consolidated revenues declined 1.9% year-over-year to ₹9,383 crore, while Q4 FY25 revenues were flat at ₹2,134 crore.
Board approved audited results for FY25 with unmodified audit opinions; final dividend of Rs. 11 per share recommended.
Recognized for sustainability achievements, including CII Climate Action Program award and leadership ratings in climate, forest, and water disclosures.
32,204 equity shares allotted under ESOP scheme; 34th AGM scheduled for August 6, 2025.
Financial highlights
Consolidated EBITDA margin (excluding non-recurring items) improved by 110 bps year-over-year to 9.0%; PAT margin rose to 4.1%.
Net profit after tax for FY25 was Rs. 403.37 crore, up from Rs. 359.45 crore in FY24; basic EPS at Rs. 22.35.
Cash generated from operations for FY25 was Rs. 1,115.88 crore; net cash from operating activities at Rs. 969.34 crore.
Operating margin for FY25 was 8.70%, up from 7.3% in FY24.
Non-recurring items and Astec losses impacted reported results; adjusted figures show stronger profitability.
Outlook and guidance
FY 2026 guidance targets 15%-18% top-line and 16%-18% bottom-line growth, mainly volume-driven.
Crop protection, animal feed, and Astec LifeSciences expected to drive growth; Astec losses projected to reduce by more than half.
Board expects to complete acquisition of remaining 48.06% stake in Creamline Dairy Products Limited by September 30, 2025.
ESG and sustainability initiatives remain a strategic priority, with ambitious emission reduction and water positivity targets.
Dairy segment targeting 10% volume growth and value-added products to exceed 40% of sales; EBITDA margin expected to rise to 6%-7%.
Latest events from Godrej Agrovet
- Q3 FY26 revenue grew 11% to ₹2,718 crore, with 23% PBT and 33.9% adjusted PAT growth.GODREJAGRO
Q3 25/268 Jul 2026 - Q1 FY26 delivered double-digit revenue and profit growth, led by Vegetable Oil and Astec LifeSciences.GODREJAGRO
Q1 25/2619 Jun 2026 - Profit and margins surged in Q1 FY25; new feed plant and Tyson Foods acquisition approved.GODREJAGRO
Q1 24/2519 Jun 2026 - FY26 revenue hit INR 10,233 crore with strong profit, margin gains, and a Rs. 11 dividend.GODREJAGRO
Q4 25/264 May 2026 - Q3 FY25 profit and margins rose, led by Animal Feed and Vegetable Oil; borrowing plan deferred.GODREJAGRO
Q3 24/253 Feb 2026 - Profit and margin gains offset revenue drop; full Godrej Tyson Foods ownership and ESG progress.GODREJAGRO
Q2 24/2518 Jan 2026 - H1 FY26 revenue up 8% with strong Animal Feed and Vegetable Oil, but Crop Protection lagged.GODREJAGRO
Q2 25/2613 Nov 2025